COFACE SA (EPA:COFA)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,356	2,147	1,763	1,810	1,867	1,231
Market Cap Growth	25.12%	21.81%	-2.60%	-3.06%	51.68%	-25.68%
Enterprise Value	5,780	5,317	4,873	4,670	4,516	3,381
PE Ratio	9.69	8.23	7.33	7.53	8.34	14.85
PS Ratio	1.24	1.13	0.94	0.99	1.17	0.83
PB Ratio	1.12	0.98	0.86	0.90	0.87	0.62
P/FCF Ratio	14.79	6.57	6.56	4.28	6.03	7.67
P/OCF Ratio	12.62	6.08	5.99	3.97	5.71	6.33
EV/Sales Ratio	3.04	2.80	2.59	2.55	2.83	2.29
EV/EBITDA Ratio	13.31	11.51	11.30	11.44	14.10	20.15
EV/EBIT Ratio	15.50	12.64	11.99	12.20	15.03	21.93
EV/FCF Ratio	36.29	16.28	18.13	11.03	14.58	21.07
Debt / Equity Ratio	1.84	1.73	1.85	1.75	1.48	1.40
Debt / EBITDA Ratio	8.89	7.90	8.44	8.28	9.38	16.13
Debt / FCF Ratio	24.24	11.62	14.11	8.36	10.24	17.43
Quick Ratio	0.96	0.93	0.98	0.86	0.75	0.73
Current Ratio	1.04	1.02	1.06	0.94	0.88	0.90
Asset Turnover	0.24	0.24	0.24	0.24	0.21	0.20
Return on Equity (ROE)	11.86%	12.29%	11.81%	11.57%	10.81%	4.23%
Return on Assets (ROA)	2.93%	3.29%	3.28%	3.06%	2.41%	1.29%
Return on Capital (ROIC)	3.98%	4.44%	4.46%	4.40%	3.72%	2.02%
Earnings Yield	10.32%	12.16%	13.64%	13.28%	11.99%	6.73%
Earnings Yield	10.32%	12.16%	13.64%	13.28%	11.99%	6.73%
FCF Yield	6.76%	15.21%	15.25%	23.38%	16.59%	13.03%
Dividend Yield	8.87%	10.59%	13.00%	16.63%	18.09%	10.67%
Payout Ratio	86.03%	74.43%	94.37%	93.17%	36.63%	-
Buyback Yield / Dilution	-0.07%	-0.08%	0.01%	-0.01%	0.88%	0.53%
Total Shareholder Return	8.80%	10.51%	13.01%	16.62%	18.98%	11.20%

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.